Hematology Test Articles & Analysis
5 news found
The primary endpoint of the study is the incidence of treatment-emergent adverse events (TEAEs), serious TEAEs, TEAEs of special interest, discontinuations from at home study treatment, and clinically significant abnormalities in laboratory tests (hematology, serum chemistry, and urinalysis). About UGN-102 (mitomycin for intravesical solution) UGN-102 consists ...
The company identified PixCell as a good fit for its strategy of entering the diagnostics and point-of-care testing space, with a purpose of distributing specialized diagnostic reagents and miniaturized medical devices. ...
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced an exclusive distribution agreement with Axonlab, a leader in point-of-care testing in Europe providing the healthcare sector with equipment and services in the fields of medical diagnostics, life science, and software solutions, to distribute the HemoScreen™, PixCell's ...
PixCell Medical, innovator of rapid diagnostic solutions at the point-ofcare, today announced a partnership with Triolab, the largest diagnostics distributor in the Nordic and Baltic countries, to be the sole distributor in Sweden of the HemoScreen™, PixCell’s hematology analyzer designed for use at the point of care. “PixCell’s HemoScreen brings ...
The paper, titled A Novel Approach to Hematology Testing at the Point-Of-Care, compares the traditional analysis methods used for blood cell counting to the new imaging flow cytometry method used by the HemoScreen. It shows that imaging is superior to the conventional methods by its ability to better differentiate between cells and being more robust in coping ...